Welcome to our dedicated page for Talkspace news (Ticker: TALK), a resource for investors and traders seeking the latest updates and insights on Talkspace stock.
Talkspace, Inc. provides virtual behavioral healthcare through a web and mobile platform for therapy, psychiatry, medication management and self-guided mental health resources. News about TALK centers on access through health insurance plans, employee assistance programs, employer and government benefits, partnerships with healthcare and life sciences organizations, and the integration of Wisdo Health, its AI-powered social health and peer support platform.
Recurring updates also include operating and financial results, investor conference communications, material agreements, shareholder voting matters and corporate-transaction related governance coverage. The company operates as a single segment and serves individual, enterprise and institutional channels within digital mental health care.
Talkspace (NASDAQ: TALK) will release its 2022 full year and fourth quarter results on February 21, 2023, post market close. A conference call to discuss these results is scheduled for February 22, 2023, at 8:30am ET. The call can be accessed via audio webcast or by dialing a dedicated participant number. Talkspace is a leading provider of virtual behavioral healthcare, committed to providing access to high-quality mental healthcare. The company currently covers approximately 86 million lives through partnerships with various health programs, underscoring its extensive reach in the mental health sector.
Talkspace (Nasdaq: TALK) has released early findings from a study on asynchronous text therapy during the COVID-19 pandemic, involving 601 healthcare workers (HCWs). The study revealed that 56% of participants reported significant improvements in anxiety and depression symptoms after just three weeks. These findings indicate a substantial effect size comparable to traditional therapy. Additionally, half of the HCWs indicated that their mental health issues predated the pandemic, while the other half faced stressors related to COVID, including fears of patient deaths. The research underscores the importance of accessible mental health support for HCWs during challenging times.
Talkspace (NASDAQ: TALK) was recognized as one of Built In's 2023 Best Hybrid Places to Work, highlighting its commitment to a supportive workplace culture. This award, now in its fifth year, honors companies emphasizing employee connection and wellness. Talkspace offers comprehensive benefits including generous PTO, wellness stipends, and retirement plans, catering to its remote workforce. By providing virtual mental health services, Talkspace covers approximately 86 million lives through various partnerships, demonstrating its significant market presence in behavioral healthcare.
Talkspace (Nasdaq: TALK), a prominent behavioral healthcare provider, announced its participation in the 41st Annual J.P. Morgan Healthcare Conference. CEO Dr. Jon R. Cohen and CFO Jennifer Fulk will present on January 12, 2023, at 11:15 a.m. PST. Presentation materials will be accessible online. Talkspace offers a variety of mental health services via a secure platform, reaching approximately 86 million lives through partnerships with insurance and employee assistance programs. Their innovative approach allows clients to connect with licensed therapists through various communication methods.
Talkspace (NASDAQ: TALK) has been recognized as the “Best Large Service” by Verywell Mind in its 2022 Online Therapy Awards, evaluating 55 online therapy companies. The award highlights Talkspace's commitment to making mental health care accessible and affordable. Their platform accommodates users through various subscription plans and covers approximately 86 million lives as of September 30, 2022. The recognition underscores Talkspace's innovative approach to therapy, including text-based communication and therapist matching.
Talkspace (Nasdaq: TALK) announced participation in the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, featuring CEO Jon R. Cohen, M.D., and CFO Jennifer Fulk. Talkspace is a leading virtual behavioral healthcare company dedicated to providing accessible mental health services, including therapy and medication management, to improve overall health and well-being. As of September 30, 2022, the company covered approximately 86 million lives through collaborations with employers and health plans.
Talkspace reported a strong increase in B2B revenue, adding approximately 9 million eligible lives and 10 new enterprise accounts in Q3 2022. Total revenue reached $29.3 million, an 11% increase year-over-year, driven by a 117% spike in B2B revenue. Despite the growth, B2C revenue declined by 33%, leading to a net loss of $18 million. Adjusted EBITDA loss improved to $15 million from $21 million. Operating expenses also decreased by 13%, reflecting efforts to enhance efficiencies.
Talkspace Appoints Dr. Jon R. Cohen as CEO
Talkspace (NASDAQ: TALK) has named Dr. Jon R. Cohen as its new Chief Executive Officer, effective immediately. Cohen, a board director since September 2022, is a veteran in healthcare with over 30 years of experience. He has a successful background in scaling technology-driven healthcare companies, notably at BioReference Laboratories. Cohen aims to enhance Talkspace’s B2B platform and expand its member base, driving best-in-class mental health care delivery.
Talkspace (Nasdaq: TALK) will announce its Q3 2022 financial results on November 8, 2022, before the market opens. A conference call to discuss these results will take place at 8:30 a.m. ET. Interested parties can join the call via an audio webcast or by calling in at specified numbers for U.S. and international participants. Talkspace provides innovative virtual mental healthcare services, covering approximately 77 million lives as of June 30, 2022, through various partnerships.
Talkspace, Inc. (Nasdaq: TALK) held its first Annual Meeting of Stockholders on September 15, 2022, where shareholders approved all proposed measures. Notably, Dr. Jon Cohen was elected to the board, bringing over 30 years of healthcare experience. He replaces Jeffrey Crowe with a term ending in 2025. Michael Hansen was appointed to complete Charles Berg's term as a Class II director expiring in 2023. The meeting also saw the re-election of Erez Shachar and Madhu Pawar, ratification of independent auditors, and approval of executive compensation reviews.